Late-Stage Comparability Of The Manufacturing Process

Source: Cytiva

During this segment of the presentation, Nimi Chhina, Ph.D., J.D. Executive Director, Head of Global R&D and Regulatory Policy Global Regulatory Affairs, Worldwide Research & Development at BioMarin Pharmaceutical Inc. and Robert G. Pietrusko, Pharm.D., Chief Regulatory & Quality Officer at Vor Biopharma share the biggest hurdles biotechs face in workflows as well as ways to reduce the workflow risk. Listen in to learn what Chhina and Pietrusko discuss about workflow impact on patient safety.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene